Director
Biotechnology innovation organization
Dr. Leslie Harden is a Director in the Science & Regulatory Policy Team at Biotechnology Innovation Organization, where she facilitates task forces focused on Digital Endpoints, Decentralized Clinical Trials, Genomic Health Data, Patient Focused Drug Development, and Rare Diseases and Orphan Drugs, and more. She is also a driver of clinical trial diversity efforts for BIO, working directly with other non-profits, research institutes, and community leaders to determine how biotech’s can best improve their patient diversity and expand their resources to underrepresented patient; and she served on the content development team for the recently launched BIO Clinical Trials: The Power of Participation website CTPoP.org. Leslie earned her Doctor of Pharmacy degree from the Hampton University School of Pharmacy, completed a post-doctoral fellowship in Global Regulatory Strategy, and has over a decade of government and industry regulatory experience.
Disclosure information not submitted.
Tuesday, September 13, 2022
2:00 PM – 3:00 PM MST
Tuesday, September 13, 2022
3:30 PM – 4:30 PM MST